BRANMOOR
THURSDAY · 14 MAY 2026

FDA Recall D-0047-2024

VistaPharm LLC · Largo, FL

Class I — life-threatening Terminated 195 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death.

Product

Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771 USA, NDC 66689-305-16

Lot / code: Lot#: 810300, Exp 10/2023

Quantity: 180 bottles

Reason for recall

Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.

Recall record

Recall number
D-0047-2024
Classification
Class I
Status
Terminated
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Letter
Distribution
USA Nationwide
Recall initiated
2023-10-18
Classified by FDA Center
2023-10-16
FDA published
2023-10-25
Terminated
2024-04-30
Recalling firm
VistaPharm LLC
Firm location
Largo, FL

Drug identification

Brand name(s)
SUCRALFATE
Generic name(s)
SUCRALFATE
Manufacturer(s)
VistaPharm, LLC
NDC(s)
66689-305
Route(s)
ORAL

‹ All recalls